Patterns in the Sequential Treatment of Patients With Rheumatoid Arthritis Starting a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug: 10‐Year Experience From a US‐Based Registry

Patterns in the Sequential Treatment of Patients With Rheumatoid Arthritis Starting a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug: 10‐Year Experience From a US‐Based Registry

Objective Developing and evaluating new treatment guidelines for rheumatoid arthritis (RA) based on observational data requires a quantitative understanding of patterns in current treatment practice with biologic and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs). Methods We u...

Full description

Bibliographic Details
Main Authors: Anton Matsson, Daniel H. Solomon, Margaux M. Crabtree, Ryan W. Harrison, Heather J. Litman, Fredrik D. Johansson
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11621

Internet

https://doi.org/10.1002/acr2.11621

Similar Items